✦ LIBER ✦

Plasminogen activator inhibitor-1 and the risk of Type 2 diabetes mellitus in American Indians: the Strong Heart Study

✍ Scribed by M. Davidson; J. Zhu; W. Lu; R. P. Tracy; D. C. Robbins; H. E. Resnick; G. Ruotolo; B. V. Howard; the Strong Heart Study Investigators

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of the relationship between t

✍ B. Myrup; P. Rossing; T. Jensen; J. Gram; C. Kluft; J. Jespersen 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Effects of gliclazide on platelet aggreg

✍ Hiroyuki Konya; Yoshikazu Hasegawa; Tomoya Hamaguchi; Kahori Satani; Akiko Umeha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 439 KB

Urokinase-Type Plasminogen Activator/Typ

✍ Pia Ragno; Nunzia Montuori; Guido Rossi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

Study on effect of different dosages of

✍ Xue Xian-zhong; Zhang Zhao-hua; Xing Xiao-yan 📂 Article 📅 2003 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 444 KB

Polymorphisms of the plasminogen activat

✍ M.W. Mansfield; M.H. Stickland; A.M. Carter; P.J. Grant 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A Longitudinal Study of Risk Factors for

✍ Jiaqiong Xu; Elisa T. Lee; Richard B. Devereux; Jason G. Umans; Jonathan N. Bell 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 148 KB